Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 641 participants.

Also called NCT01415531

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 641 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01415531
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01415531. Randomized; triple masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-03 (actual). Results posted on 2013-05-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
Condition
Hypertension
Intervention (Drug)
Nebivolol
Intervention (Drug)
Placebo
Lead sponsor
Forest Laboratories (class: industry)

Record details

Record id
cardio:ct-nct01415531
Content hash
858cca55352f927447883f410acfea35ebc9dda5a9182344cf1f7d11e734d0ed